| Net income (loss) | |
| Depreciation and amortization | 3.19M |
| Taxes | 465K |
| Stock-based compensation expense | 3.93M |
| Provision for excess inventory | 1.14M |
| Accounts receivable | -7.9M |
| Inventories | -7.53M |
| Prepaid expenses and other current assets | -58K |
| Accounts payable & other current liabilities | -4.12M |
| Deferred revenue | -704K |
| Income taxes | 85K |
| Other assets and liabilities | -8.49M |
| Net cash provided by (used for) operating activities | |
| Expenditures for property, plant, and equipment | -2.26M |
| (Increase) decrease in restricted cash | |
| Net cash provided by (used for) investing activities | |
| Financing fees and other expenses | |
| Proceeds from exercise of stock options | 1.74M |
| Proceeds from Employee Stock Purchase Plan | 0 |
| Net cash provided by (used for) financing activities | |
| Effect of exchange rate changes on cash | |
| Net increase (decrease) in cash and cash equivalents | -13.27M |
| Cash and cash equivalents at beginning of period | 78.89M |
| Cash and cash equivalents at end of period | 65.62M |